Rakuten Securities Inc. Makes New Investment in Astera Labs, Inc. $ALAB

Rakuten Securities Inc. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, HoldingsChannel.com reports. The fund purchased 5,590 shares of the company’s stock, valued at approximately $2,700,000. Astera Labs accounts for 0.6% of Rakuten Securities Inc.’s portfolio, making the stock its 26th biggest position.

Several other institutional investors have also modified their holdings of ALAB. Reflection Asset Management acquired a new position in shares of Astera Labs in the 4th quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs during the 2nd quarter worth approximately $25,000. Smartleaf Asset Management LLC raised its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs in the fourth quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC lifted its stake in Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB stock opened at $284.97 on Friday. The firm’s 50-day moving average is $352.70 and its 200-day moving average is $244.92. The stock has a market cap of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period last year, the business posted $0.44 EPS. Astera Labs’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research reports. Barclays increased their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday. Morgan Stanley increased their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $333.00.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.